ECU Health Medical Center has completed its first procedure using a new non-invasive technology designed to treat liver ...
SHREVEPORT, La. - Patients diagnosed with liver cancer in the ArkLaTex now have access to a new treatment option closer to ...
Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...
Please provide your email address to receive an email when new articles are posted on . For lesions of unknown etiology, the ACG recommends multiphasic contrast-enhanced imaging. The ACG recommends ...
Focused ultrasound creates precise mechanical cavitation that liquefies tumor tissue while sparing adjacent parenchyma, avoiding thermal sink effects and reducing risk near major vessels and bile ...
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting ...
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial The IMbrave150 study's atezo-bev group was ...
Diet’s protective role: Rutgers-led research found low-protein diets slowed liver tumor growth in mice, suggesting benefits ...
TriSalus Life Sciences Inc. (NASDAQ:TLSI) is one of the best fast growing penny stocks to buy right now. On May 4, TriSalus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results